SELLAS Life Sciences Group, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-5.0M | $6.0M |
| FY2017 | $2.6M | $2.1M | $2.3M |
| FY2018 | $0 | $5.2M | $5.3M |
| FY2019 | — | $6.1M | $7.3M |
| FY2020 | — | $28.0M | $35.3M |
| FY2021 | — | $20.3M | $21.4M |
| FY2022 | — | $4.9M | $17.1M |
| FY2023 | — | $-8.0M | $2.5M |
| FY2024 | — | $9.5M | $13.9M |
| FY2025 | — | $70.9M | $71.8M |